Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

299,334 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study.
Li JY, Hou XR, Chen SY, Liu X, Zhong QZ, Qian LT, Qiao XY, Wang H, Zhu Y, Cao JZ, Wu JX, Wu T, Zhu SY, Shi M, Zhang HL, Zhang XM, Su H, Song YQ, Zhu J, Zhang YJ, Huang HQ, Wang Y, He X, Zhang LL, Qu BL, Yang Y, Hu C, Deng M, Wang SL, Qi SN, Li YX. Li JY, et al. Among authors: wang h, wang y, wang sl. Ann Hematol. 2023 Sep;102(9):2459-2469. doi: 10.1007/s00277-023-05311-5. Epub 2023 Jun 12. Ann Hematol. 2023. PMID: 37306711 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 36707962
Characteristics and prognosis of distant metastasis after primary treatment for early-stage extranodal nasal-type natural killer/T-cell lymphoma from the China Lymphoma Collaborative Group database.
Zheng X, Qu BL, Liu X, Zhong QZ, Qian LT, Yang Y, Hou XR, Qiao XY, Wang H, Zhu Y, Cao JZ, Wu JX, Wu T, Zhu SY, Shi M, Zhang HL, Zhang XM, Su H, Song YQ, Zhu J, Zhang YJ, Huang HQ, Wang Y, Chen F, Yin L, He X, Zhang LL, Li YX, Qi SN. Zheng X, et al. Among authors: wang h, wang y. EJHaem. 2022 Nov 25;4(1):78-89. doi: 10.1002/jha2.613. eCollection 2023 Feb. EJHaem. 2022. PMID: 36819187 Free PMC article.
Clinical characteristics, treatment, and survival of 30 patients with gastrointestinal natural killer/T-cell lymphoma.
Liu JX, Liu X, Yang Y, Liu WP, Wang Y, He X, Zhang LL, Qu BL, Qian LT, Hou XR, Qiao XY, Wang H, Li GF, Zhu Y, Cao JZ, Wu JX, Wu T, Zhu SY, Shi M, Zhang HL, Su H, Zhang YJ, Zhu J, Qi SN, Li YX, Song YQ. Liu JX, et al. Among authors: wang h, wang y. Cancer Rep (Hoboken). 2023 May;6(5):e1800. doi: 10.1002/cnr2.1800. Epub 2023 Mar 15. Cancer Rep (Hoboken). 2023. PMID: 36919649 Free PMC article.
Evidence of cure for extranodal nasal-type natural killer/T-cell lymphoma with current treatment: an analysis of the CLCG database.
Liu X, Zhang LL, Qu BL, Zhong QZ, Qian LT, Yang Y, Hou XR, Qiao XY, Wang H, Zhu Y, Cao JZ, Wu JX, Wu T, Zhu SY, Shi M, Zhang HL, Zhang XM, Su H, Song YQ, Zhu J, Zhang YJ, Huang HQ, Wang Y, Chen F, Yin L, He X, Cai S, Li YX, Qi SN. Liu X, et al. Among authors: wang h, wang y. Haematologica. 2023 Sep 1;108(9):2467-2475. doi: 10.3324/haematol.2022.281847. Haematologica. 2023. PMID: 36951150 Free PMC article.
Preoperative short-course radiotherapy followed by chemotherapy and PD-1 inhibitor administration for locally advanced rectal cancer: A study protocol of a randomized phase II/III trial (STELLAR II study).
Zhang W, Tang Y, Wei L, Liu S, Wang W, Chi Y, Wang Y, Kang W, Huang W, Deng F, Li H, Ma H, Jiang L, Ding Z, Feng L, Li Y, Chen Y, Zhou H, Hu C, Jin J. Zhang W, et al. Among authors: wang w, wang y. Colorectal Dis. 2024 Sep;26(9):1732-1740. doi: 10.1111/codi.17090. Epub 2024 Jul 17. Colorectal Dis. 2024. PMID: 39020518
Optimizing the combination of chemotherapeutic drugs along with radiotherapy for extranodal NK/T-cell lymphoma.
Luo F, Zhong QZ, Liu X, Hou XR, Qian LT, Qiao XY, Wang H, Zhu Y, Cao JZ, Wu JX, Wu T, Zhu SY, Shi M, Zhang HL, Zhang XM, Su H, Song YQ, Zhu J, Zhang YJ, Huang HQ, Wang Y, He X, Zhang LL, Qu BL, Yang Y, Hu C, Deng M, Wang SL, Qi SN, Li YX. Luo F, et al. Among authors: wang h, wang y, wang sl. Ther Adv Med Oncol. 2024 Oct 1;16:17588359241285981. doi: 10.1177/17588359241285981. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 39399411 Free PMC article.
HLX07 alone or combined with serplulimab, cisplatin and 5-fluorouracil for advanced esophageal squamous cell carcinoma: A phase 2 study.
Liu Y, Wang Y, Zhu Y, Wu T, Liu Z, Zhou J, Yuan Y, Yang M, Liu B, Tan Z, Zhuang W, Chen J, Li N, Wang Y, Hu X, Wang L, Yu H, Wang Q, Zhu J, Huang J. Liu Y, et al. Among authors: wang l, wang y, wang q. Cancer Commun (Lond). 2024 Dec;44(12):1431-1443. doi: 10.1002/cac2.12621. Epub 2024 Oct 24. Cancer Commun (Lond). 2024. PMID: 39446605 Free PMC article. Clinical Trial.
[A comparative clinical study of modified IA "3+4" regimen and intermediate-dose cytarabine regimen in the consolidation treatment of low-risk acute myeloid leukemia].
Liu XH, Jia JS, Wang J, Gong LZ, Tang FF, Yu WJ, Zhu XL, Wang Y, Jiang Q, Chang YJ, Zhao XS, Ruan GR, Qin YZ, Huang XJ, Jiang H. Liu XH, et al. Among authors: wang j, wang y. Zhonghua Xue Ye Xue Za Zhi. 2022 Jul 14;43(7):594-597. doi: 10.3760/cma.j.issn.0253-2727.2022.07.011. Zhonghua Xue Ye Xue Za Zhi. 2022. PMID: 36709138 Free PMC article. Chinese. No abstract available.
299,334 results
You have reached the last available page of results. Please see the User Guide for more information.